VEGF and Notch in tip and stalk cell selection

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 1, 2013, Pages

  Blanco, Raquel ^a   Gerhardt, Holger ^a  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; NOTCH RECEPTOR; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; CELL MOTION; ENDOTHELIUM CELL; GENETICS; HUMAN; METABOLISM; PHENOTYPE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL MOVEMENT; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MLCS; MLOWN;

EID: 84874491536     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a006569     Document Type: Article

References (106)

1. Autiero M., Waltenberger J, CommuniD, Kranz A, Moons L, Lambrechts D., Kroll J, Plaisance S, De Mol M, Bono F, et al. 2003. Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9: 936-943.
2. Barleon B., Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343.
3. Bellon A., Luchino J, Haigh K, Rougon G, Haigh J, Chauvet S, Mann F. 2010. VEGFR2 (KDR/Flk1) signalling mediates axon growth in response to semaphorin 3E in the developing brain. Neuron 66: 205-219.
4. Benedito R., Roca C, Sorensen I, Adams S, Gossler A, Fruttiger M, Adams RH. 2009. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137: 1124-1135.
5. Bentley K., Gerhardt H, Bates PA. 2008. Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation. J Theor Biol 250: 25-36.
6. Bentley K., Mariggi G, Gerhardt H, Bates PA. 2009. Tipping the balance: Robustness of tip cell selection, migration and fusion in angiogenesis. PLoS Comput Biol 5: e1000549. doi: 10.1371/journal.pcbi.1000549.
7. Bettenhausen B., Gossler A. 1995. Efficient isolation of novel mouse genes differentially expressed in early postimplantation embryos. Genomics 28: 436-441.
8. Bray SJ. 2006. Notch signalling: A simple pathway becomes complex. Nat Rev 7: 678-689.
9. Carmeliet P., Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M., Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C., et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
10. Casanovas O., Hicklin DJ, Bergers G, Hanahan D. 2005. Drug resistance by evasion of antiangiogenic targeting of VEGF signalling in late-stage pancreatic islet tumors. Cancer Cell 8: 299-309.
11. Claxton S., Fruttiger M. 2004. Periodic Delta-like 4 expression in developing retinal arteries. Gene Expr Patterns 5: 123-127.
12. Covassin L.D., Villefranc JA, Kacergis MC, Weinstein BM, Lawson ND. 2006. Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish. Proc Natl Acad Sci 103: 6554-6559.
13. Davis R.L., Turner DL. 2001. Vertebrate hairy and Enhancer of split related proteins: Transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 20: 8342-8357.
14. Dejana E., Tournier-Lasserve E, Weinstein BM. 2009. The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications. Dev Cell 16: 209-221.
15. Duarte A., Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E., Costa L, HenriqueD, Rossant J. 2004. Dosagesensitive requirement for mouse Dll4 in artery development. Genes Dev 18: 2474-2478.
16. Dumont D.J., Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Breitman M, Alitalo K. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282: 946-949.
17. Dunwoodie S.L., Henrique D, Harrison SM, Beddington RS. 1997. Mouse Dll3: A novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse embryo. Development 124: 3065-3076.
18. Dvorak HF. 2005. Angiogenesis: Update 2005. J Thromb Haemost 3: 1835-1842.
19. Ellisen L.W., Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J. 1991. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66: 649-661.
20. Ferrara N. 2004. Vascular endothelial growth factor as a target for anticancer therapy. Oncologist 9: 2-10.
21. Ferrara N., Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, MooreMW. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
22. Ferrara N., Gerber HP, LeCouter J. 2003. The biology of VEGF and its receptors. Nat Med 9: 669-676.
23. Fisher N.D., Hughes M, Gerhard-Herman M, Hollenberg NK. 2003. Flavanol-rich cocoa induces nitric-oxidedependent vasodilation in healthy humans. J Hypertens 21: 2281-2286.
24. Fong G.H., Rossant J, Gertsenstein M, Breitman ML. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70.
25. Fruttiger M. 2002. Development of the mouse retinal vasculature: Angiogenesis versus vasculogenesis. Invest Ophthalmol Vis Sci 43: 522-527.
26. Fryer C.J., Lamar E, Turbachova I, Kintner C, Jones KA. 2002. Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes Dev 16: 1397-1411.
27. Funahashi Y., Hernandez SL, Das I, Ahn A, Huang J, Vorontchikhina M, Sharma A, Kanamaru E, Borisenko V, Desilva D.M., et al. 2008. A notch1 ectodomain construct inhibits endothelial notch signalling, tumor growth, and angiogenesis. Cancer Res 68: 4727-4735.
28. Funahashi Y., Shawber CJ, Vorontchikhina M, Sharma A, Outtz H.H., Kitajewski J. 2010. Notch regulates the angiogenic response via induction of VEGFR-1. J Angiogenes Res 2: 3. doi: 10.1186/2040-2384-2-3.
29. Gale N.W., Dominguez MG, Noguera I, Pan L, Hughes V, Valenzuela D.M., Murphy AJ, Adams NC, Lin HC, Holash J, et al. 2004. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci 101: 15949-15954.
30. Gerhardt H., Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D., et al. 2003. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161: 1163-1177.
31. Harrington L.S., Sainson RC, Williams CK, Taylor JM, ShiW, Li J.L., Harris AL. 2008. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvasc Res 75: 144-154.
32. Hayashi H., Kume T. 2008. Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signalling pathways in endothelial cells. PLoS ONE 3: e2401. doi: 10.1371/journal.pone.0002401.
33. Hellstrom M., Phng LK, Gerhardt H. 2007a. VEGF and Notch signalling: The yin and yang of angiogenic sprouting. Cell Adh Migr 1: 133-136.
34. Hellstrom M., Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P., Alva J, Nilsson AK, Karlsson L, Gaiano N, et al. 2007b. Dll4 signalling throughNotch1 regulates formation of tip cells during angiogenesis. Nature 445: 776-780.
35. Hoey T., Yen WC, Axelrod F, Basi J, Donigian L, Dylla S, Fitch-Bruhns M, Lazetic S, Park IK, Sato A, et al. 2009. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 5: 168-177.
36. Hofmann J.J., Luisa Iruela-Arispe M. 2007. Notch expression patterns in the retina: An eye on receptor-ligand distribution during angiogenesis. Gene Expr Patterns 7: 461-470.
37. Holash J., Davis S, Papadopoulos N, Croll SD, Ho L, Russell M, Boland P, Leidich R, Hylton D, Burova E, et al. 2002. VEGF-Trap: A VEGF blocker with potent antitumor effects. Proc Natl Acad Sci 99: 11393-11398.
38. Iruela-Arispe ML, Davis GE. 2009. Cellular and molecular mechanisms of vascular lumen formation. Dev Cell 16: 222-231.
39. Iso T., Kedes L, Hamamori Y. 2003. HES and HERP families: Multiple effectors of the Notch signalling pathway. J Cell Physiol 194: 237-255.
40. Isogai S., Lawson ND, Torrealday S, Horiguchi M, Weinstein BM. 2003. Angiogenic network formation in the developing vertebrate trunk. Development 130: 5281-5290.
41. Jain R.K., Duda DG, Clark JW, Loeffler JS. 2006. Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 3: 24-40.
42. Jakobsson L., Franco CA, Bentley K, Collins RT, Ponsioen B, Aspalter I.M., Rosewell I, Busse M, Thurston G, Medvinsky A, et al. 2010. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol 12: 943-953.
43. Jeffries S., Robbins DJ, Capobianco AJ. 2002. Characterization of a high-molecular-weight Notch complex in the nucleus of Notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line. Mol Cell Biol 22: 3927-3941.
44. Kageyama R., Masamizu Y, Niwa Y. 2007. Oscillator mechanism of Notch pathway in the segmentation clock. Dev Dyn 236: 1403-1409.
45. Kao H.Y., Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M., Kintner CR, Evans RM, Kadesch T. 1998. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev 12: 2269-2277.
46. Karsan A. 2005. The role of notch in modeling and maintaining the vasculature. Can J Physiol Pharmacol 83: 14-23.
47. Kerbel R.S., Yu J, Tran J, Man S, Viloria-Petit A, Klement G, Coomber B.L., Rak J. 2001. Possible mechanisms of acquired resistance to anti-angiogenic drugs: Implications for the use of combination therapy approaches. Cancer Metastasis Rev 20: 79-86.
48. Kim K.J., Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844.
49. Krebs L.T., Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, et al. 2000. Notch signalling is essential for vascular morphogenesis in mice. Genes Dev 14: 1343-1352.
50. Krebs L.T., Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T. 2004. Haploinsufficient lethality and formation of arteriovenous malformations inNotch pathway mutants. Genes Dev 18: 2469-2473.
51. Krueger J., Liu D, Scholz K, Zimmer A, Shi Y, Klein C, Siekmann A, Schulte-Merker S, Cudmore M, Ahmed A, et al. 2011. Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo. Development 138: 2111-2120.
52. Lardelli M., Dahlstrand J, Lendahl U. 1994. The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium. Mech Dev 46: 123-136.
53. Lawson N.D., Vogel AM, Weinstein BM. 2002. sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell 3: 127-136.
54. Lecourtois M., Schweisguth F. 1995. The neurogenic suppressor of hairless DNA-binding protein mediates the transcriptional activation of the enhancer of split complex genes triggered by Notch signalling. Genes Dev 9: 2598-2608.
55. Leslie J.D., Ariza-McNaughton L, Bermange AL, McAdow R, Johnson S.L., Lewis J. 2007. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 134: 839-844.
56. Li J.L., Sainson RC, Shi W, Leek R, Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA, et al. 2007. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 67: 11244-11253.
57. Li J.L., Jubb AM, Harris AL. 2010. Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicity. Future Oncol 6: 1099-1103.
58. Limbourg F.P., Takeshita K, Radtke F, Bronson RT, Chin MT, Liao JK. 2005. Essential role of endothelial Notch1 in angiogenesis. Circulation 111: 1826-1832.
59. Lindsell C.E., Shawber CJ, Boulter J, Weinmaster G. 1995. Jagged: A mammalian ligand that activates Notch1. Cell 80: 909-917.
60. Liu Z.J., Shirakawa T, Li Y, Soma A, Oka M, Dotto GP, Fairman R.M., Velazquez OC, Herlyn M. 2003. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: Implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 23: 14-25.
61. Lobov I.B., Renard RA, Papadopoulos N, GaleNW, Thurston G, Yancopoulos GD, Wiegand SJ. 2007. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci 104: 3219-3224.
62. Louvi A., Artavanis-Tsakonas S. 2006. Notch signalling in vertebrate neural development. Nat Rev Neurosci 7: 93-102.
63. Lu X., LeNoble F, Yuan L, Jiang Q, De Lafarge B, SugiyamaD, Breant C., Claes F, De Smet F, Thomas JL, et al. 2004. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 432: 179-186.
64. Mailhos C., Modlich U, Lewis J, Harris A, Bicknell R, Ish-Horowicz D. 2001. Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 69: 135-144.
65. Mumm J.S., Kopan R. 2000. Notch signalling: From the outside in. Dev Biol 228: 151-165.
66. Muramatsu M., Yamamoto S, Osawa T, Shibuya M. 2010. Vascular endothelial growth factor receptor-1 signalling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth. Cancer Res 70: 8211-8221.
67. Nakagawa O., McFadden DG, Nakagawa M, Yanagisawa H, Hu T., Srivastava D, Olson EN. 2000. Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signalling. Proc Natl Acad Sci 97: 13655-13660.
68. Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P., Gale NW, Lin HC, Yancopoulos GD, Thurston G. 2006. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444: 1032-1037.
69. Olsson A.K., Dimberg A, Kreuger J, Claesson-Welsh L. 2006. VEGF receptor signalling-In control of vascular function. Nat Rev 7: 359-371.
70. Park J.E., Keller GA, Ferrara N. 1993. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4: 1317-1326.
71. Park J.E., Chen HH, Winer J, Houck KA, Ferrara N. 1994. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269: 25646-25654.
72. Patel N.S., Li JL, GeneraliD, Poulsom R, CranstonDW, Harris AL. 2005. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res 65: 8690-8697.
73. Phng L.K., Gerhardt H. 2009. Angiogenesis: A team effort coordinated by notch. Dev Cell 16: 196-208.
74. Phng L.K., Potente M, Leslie JD, Babbage J, Nyqvist D, Lobov I, Ondr JK, Rao S, Lang RA, Thurston G, et al. 2009. Nrarp coordinates endothelial Notch and Wnt signalling to control vessel density in angiogenesis. Dev Cell 16: 70-82.
75. Radtke F., Clevers H, Riccio O. 2006. From gut homeostasis to cancer. Curr Mol Med 6: 275-289.
76. Rao P.K., Dorsch M, Chickering T, Zheng G, Jiang C, Goodearl A, Kadesch T, McCarthy S. 2000. Isolation and characterization of the notch ligand delta4. Exp Cell Res 260: 379-386.
77. Reichelt M., Shi S, Hayes M, Kay G, Batch J, Gole GA, Browning J. 2003. Vascular endothelial growth factor-B and retinal vascular development in the mouse. Clin Experiment Ophthalmol 31: 61-65.
78. Ridgway J., Zhang G, Wu Y, Stawicki S, LiangWC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I, et al. 2006. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444: 1083-1087.
79. Risau W. 1997. Mechanisms of angiogenesis. Nature 386: 671-674.
80. Roukens M.G., Alloul-Ramdhani M, Baan B, Kobayashi K, Peterson-Maduro J, van Dam H, Schulte-Merker S, Baker DA. 2010. Control of endothelial sprouting by a Tel-CtBP complex. Nat Cell Biol 12: 933-942.
81. Rudge J.S., Thurston G, Davis S, Papadopoulos N, Gale N, Wiegand S.J., YancopoulosGD. 2005. VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene-based discovery of the next generation of angiogenesis targets. Cold Spring Harb Symp Quant Biol 70: 411-418.
82. Ruhrberg C., Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H, Betsholtz C, Shima DT. 2002. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 16: 2684-2698.
83. Sainson R.C., Aoto J, Nakatsu MN, Holderfield M, Conn E, Koller E., Hughes CC. 2005. Cell-autonomous notch signalling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J 19: 1027-1029.
84. Scehnet J.S., JiangW, Kumar SR, Krasnoperov V, Trindade A, Benedito R., Djokovic D, Borges C, Ley EJ, Duarte A, et al. 2007. Inhibition of Dll4-mediated signalling induces proliferation of immature vessels and results in poor tissue perfusion. Blood 109: 4753-4760.
85. Shalaby F., Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman M.L., Schuh AC. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.
86. Shawber C., Boulter J, Lindsell CE, Weinmaster G. 1996. Jagged2: A serrate-like gene expressed during rat embryogenesis. Dev Biol 180: 370-376.
87. Shutter J.R., Scully S, Fan W, Richards WG, Kitajewski J, Deblandre G.A., Kintner CR, Stark KL. 2000. Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev 14: 1313-1318.
88. Siekmann A.F., Lawson ND. 2007. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445: 781-784.
89. Smith L.E., Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA. 1994. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35: 101-111.
90. Soker S., Takashima S, Miao HQ, Neufeld G, Klagsbrun M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735-745.
91. Sorensen I., Adams RH, Gossler A. 2009. DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood 113: 5680-5688.
92. Stone J., Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E. 1995. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. JNeurosci 15: 4738-4747.
93. Suchting S., Freitas C, le Noble F, Benedito R, Breant C, Duarte A., Eichmann A. 2007. The Notch ligand Deltalike 4 negatively regulates endothelial tip cell formation and vessel branching. ProcNatl Acad Sci 104: 3225-3230.
94. Takahashi H., Shibuya M. 2005. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) 109: 227-241.
95. Takeshita K., Satoh M, Ii M, Silver M, Limbourg FP, Mukai Y, Rikitake Y., Radtke F, Gridley T, Losordo DW, et al. 2007. Critical role of endothelial Notch1 signalling in postnatal angiogenesis. Circ Res 100: 70-78.
96. Tammela T., Zarkada G, Wallgard E, Murtomaki A, Suchting S, Wirzenius M, Waltari M, Hellstrom M, Schomber T, Peltonen R., et al. 2008. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454: 656-660.
97. Tanaka K., Yamaguchi S, Sawano A, Shibuya M. 1997. Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase). Jpn J Cancer Res 88: 867-876.
98. Thurston G., Kitajewski J. 2008. VEGF and Delta-Notch: Interacting signalling pathways in tumour angiogenesis. Br J Cancer 99: 1204-1209.
99. Tischer E., Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954.
100. Uyttendaele H., Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J. 1996. Notch4/int-3, a mammary protooncogene, is an endothelial cell-specific mammalian Notch gene. Development 122: 2251-2259.
101. Uyttendaele H., Ho J, Rossant J, Kitajewski J. 2001. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci 98: 5643-5648.
102. Weinmaster G. 1998. Notch signalling: Direct or what? Curr Opin Genet Dev 8: 436-442.
103. Weinmaster G., Roberts VJ, Lemke G. 1992. Notch2: Asecond mammalian Notch gene. Development 116: 931-941.
104. Williams C.K., Li JL, Murga M, Harris AL, Tosato G. 2006. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 107: 931-939.
105. Xue Y., Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, Rand EB, Weinmaster G, Gridley T. 1999. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8: 723-730.
106. Zeng Q., Li S, Chepeha DB, Giordano TJ, Li J, Zhang H, Polverini PJ, Nor J, Kitajewski J, Wang CY. 2005. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signalling. Cancer Cell 8: 13-23.